Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S. that will no longer be administered under an emergency use authorization.

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease ...

Vaccines are available now for emergency use, but full regulatory approval could boost public confidence—and spur more schools and businesses to start requiring shots.

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

The move marks a significant shift in national vaccine policy and comes just one week after the Trump administration signaled it would limit approval for seasonal COVID boosters to seniors and ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Photo: Adobe Stock Despite the CDC’s move to kick the COVID-19 vaccine off recommended immunization schedules for children ...